TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries
Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Carsten Flohr(King's College London), Richard J. de Booij, S. Barbarot(Hotel Dieu Hospital), Christian Vestergaard(Aarhus University), Jochen Schmitt(University Hospital Carl Gustav Carus), Phyllis I. Spuls, Paula Williamson(University of Liverpool), Christian Apfelbacher(Heidelberg University), Alan D. Irvine(Trinity College Dublin), Aaron Boyce(King's College London), Stephan Weidinger(University Hospital Schleswig-Holstein), Maritza A. Middelkamp‐Hup(Amsterdam University Medical Centers), Dmitri Wall(Children's Health Ireland at Crumlin), Amanda Roberts(University of Nottingham), Mette Deleuran(Aarhus University Hospital)
Cited by 28
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
|PLoS ONE|2008|1.5k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k